Contemporary Pediatrics
WEBContemporary Pediatrics is a website for pediatricians and other health care professionals who care for children. It provides the latest news, videos, podcasts and continuing medical education on various topics in pediatrics.
FDA approves arimoclomol as first drug to treat Neimann-Pick …
WEB1 day ago · The FDA has approved the first drug to treat Neimann-Pick disease, type C (NPC) in adults and children aged 2 years and older. According to the federal agency, it has approved arimoclomol (Miplyffa; Zevra Therapeutics), in combination with the enzyme inhibitor miglustat, to treat the rare disease that results in progressive neurological symptoms and organ dysfunction.1
The April 2024 issue of Contemporary Pediatrics: Latest updates …
WEBApr 1, 2024 · Read the latest articles on pediatric irritable bowel syndrome, tapinarof cream for atopic dermatitis, COVID-19 vaccination, asthma exacerbation, tick-borne diseases, and cell phone use in children. Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, shares her message and insights on the April issue of Contemporary Pediatrics.
Guidelines - Contemporary Pediatrics
WEBFind the latest guidelines from the American Academy of Pediatrics (AAP) on various topics, such as breastfeeding, obesity, influenza, RSV, organ donation, and more. Take quizzes, read tips, and learn how to apply the evidence-based recommendations in …
News - Contemporary Pediatrics
WEBHPV vaccination progress in US-affiliated pacific islands. Joshua Fitch, Senior Editor. August 23rd 2024. A CDC report reviews HPV vaccination trends in US Pacific Islands, revealing mixed progress towards the 2030 goal of 90% completion among girls by age 15.
COVID-19 - Contemporary Pediatrics
WEBAugust 22nd 2024. The federal agency advised manufacturers in June that 2024-2025 COVID-19 vaccines should be monovalent JN.1, with the preferred lineage being the KP.2 strain.
Gastroenterology - contemporarypediatrics.com
WEBFDA approves dupilumab for eosinophilic esophagitis in children aged 1 to 11 years. Joshua Fitch, Senior Editor. January 25th 2024. The approval makes dupilumab the first and only treatment specifically indicated for eosinophilic esophagitis (EoE) patients aged 1 to 11 years that weigh at least 33 lbs (15 kg).
Latest Conference Articles - Contemporary Pediatrics
WEBRead the latest news and updates from pediatric conferences on various topics, such as influenza vaccine, gene and cell therapy, cerebral palsy, atopic dermatitis, and obesity. Contemporary Pediatrics is a peer-reviewed journal that covers clinical and research aspects of pediatrics.
Contemporary Pediatrics week in review: Updated COVID-19 …
WEBOct 6, 2023 · Tocilizumab-bavi (Tofidence; Biogen) demonstrated a biosimilarity to tocilizumab (Actemra; Genentech) based on multifaceted clinical and non-clinical data for polyarticular juvenile idiopathic arthritis (PJIA) and systemic juvenile idiopathic arthritis (sJIA) in children aged 2 years and up.
Respiratory - Contemporary Pediatrics
WEBSeptember 2nd 2024. Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the August 2024 issue of Contemporary Pediatrics.
Skip to content